The mtDNA mutator mouse: Dissecting mitochondrial involvement in








































Evidence from many paths of gerontological research 
suggests that mitochondria are one of the key players in 
aging. Not only do the number of mitochondria 
decrease in postmitotic tissues like heart, skeletal 
muscle and brain during aging [1, 2], but a number of 
age-associated structural changes of mitochondria has 
been reported as well [1, 3]. The most common aging-
associated structural changes of mitochondria are 
alterations of cristae structure, but also matrix 
vacuolization or densification and a general 
enlargement of mitochondria have been found to 
increase with age [4-6]. Mitochondrial DNA (mtDNA) 









































humans, and in many cases, have been correlated to 
mitochondrial dysfunction. Higher levels of mtDNA 
deletions were detected in postmitotic tissues e.g., 
skeletal muscle, heart and brain in contrast to kidney, 
spleen, skin and liver that are composed of dividing 
cells, indicating a tissue-specific "pattern" of deletion 
accumulation [7]. However, their possible causative 
effects have been intensely debated because of their low 
abundance (under 1% of deleted mtDNA molecules in 
whole tissue homogenate) and purely correlative 
connection with aging [8]. A real breakthrough occurred 
when it was discovered that mitochondrial dysfunction 
is unevenly distributed in tissues and that mtDNA point 
mutations and deletions accumulate in some single 
cells. For instance, the analysis of five tRNA genes 
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mutations (49%-94%) in COX-deficient skeletal muscle 
fibers isolated from aged individuals [9]. In addition, 
point mutations associated with the major regulatory 
region for replication of mtDNA were found in a high 
proportion (up to 50%) in skin fibroblasts or skeletal 
muscles of individuals above 65 years of age [10, 11].  
 
To test the causative role of mtDNA mutations in aging 
we have developed the mtDNA mutator mouse that 
accumulates high levels of point mutations due to a 
proofreading deficiency of the mitochondrial DNA 
polymerase (POLG) [12]. Subsequently, a very similar 
model was developed by another group [13]. The two 
mouse models show basically the same phenotypes, 
differing only in the time of onset of phenotypes. In our 
hands, mtDNA mutator mice are born in Mendelian 
proportions, without any visible defects, but after 6-7 
months they start to display a range of premature aging 
phenotypes, such as a weight loss, reduced subcutane-
ous fat, alopecia, kyphosis, osteoporosis, anaemia, 
reduced fertility, heart disease, sarcopenia, progressive 
hearing loss and decreased spontaneous activity [12]. 
Their lifespan is also greatly reduced compared with 
wild-type littermate controls and they die at around 46 
weeks of age [12].  
 
In addition to the standard circular chromosome, 
mtDNA mutator mice harbour large linear mtDNA 
molecules caused by replication stalling [14]. These 
molecules are around 11-12 kb in length, and 
encompass the region between the origins of replication 
for the heavy (OH) and the light strands (OL). Around 
25-30% of mtDNA consists of these linear molecules 
with deletion, and this ratio does not change as the 
animal age [12]. As these molecules exist at quite high 
levels, it has been proposed that this may also contribute 
to the progeroid phenotype of the mtDNA mutator 
mouse [12, 14]. The POLG exonuclease activity may be 
involved in the resolution of replication intermediates at 
OL, which can explain why exonuclease deficiency will 
lead to replication stalling, thus leaving the mtDNA 
molecule susceptible to breakage at the stall site [14]. It 
has also been suggested that the time needed for the 
replication of mtDNA could be prolonged in the 
mtDNA mutator mouse, as evidenced by a high amount 
of replication intermediates [14]. This prolonged 
replication is proposed to exhaust resources in the 
mitochondria. Although plausible, this hypothesis still 
requires direct experimental verification [14]. 
 
The main consequence of the mitochondrial proof-
reading deficiency in mtDNA mutator mice is the 
progressive, random accumulation of mtDNA mutations 




















Genotype  Brain ~8 weeks  Heart ~25 weeks 
WT    0,33(CS)[12] 
  0,0066 (RMC)[15] 
4,58 (CS)[12] 
2,11 (CS)[13] 
HZ    1,33 (CS) [12] 
  3,3 (RMC) [15] 
- 
- 
MUT    9 (CS)[12] 





Different approaches have been used to measure levels 
of somatic mtDNA mutations and the results often vary 
considerably depending on the method used, e.g. 
cloning-sequencing (CS) or random mutation capture 
(RMC) (Table 1.). Both of these methods seem to detect 
similar differences in levels of mutations in mice 
heterozygous (Polg
+/mut) or homozygous (Polg
mut/mut) for 
the mtDNA mutator allele. However, the RMC method 
detects a 500-fold less mtDNA mutation load in control 
mice, i.e. wild type animals obtained after intercrossing 
mice het erozygous for the mtDNA mutator allele 
(Table 1.). The CS method is the most commonly used 
procedure to estimate the level of mtDNA mutations 
and involves PCR amplification of mtDNA, followed 
by cloning and sequencing of the obtained fragment. A 
problem with this method is that PCR might introduce 
mutations in the initial step, which are then carried 
through to the sequencing reaction. The RMC was 
developed by Vermulst et al. [15] and is based on the 
fact that mtDNA mutations will alter a given restriction 
enzyme recognition site. After restriction enzyme 
digestion only mutated molecules should be amplified 
by PCR and those are subsequently quantified and 
sequenced. However, the target sequence analyzed by 
this method is only 4 bases long (Taq I recognition site) 
and may therefore not represent the rate of mutations 
over the entire molecule [15]. The RMC assay appears 
to work very well on large sample sizes when the 
mutations are evenly distributed throughout the genome 
[16]. However, when existing mutations are few but 
have been amplified, they might be missed. MtDNA 
mutations can clonally expand in certain tissues, i.e. 
when a stem cell gives rise to many cells. This can also 
happen randomly when mtDNA molecules are segregate-
ed or replicated unevenly.  In human colonic mucosa (a 
tissue known to clonally expand mtDNA  mutations) the 
RMC routinely detects between 10-1000 times less 
mutations than the CS approach and around 5 times less 
than with single-molecule-PCR based method [16]. 
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animals will be complicated when the animals are 
derived from a mother heterozygous for the mtDNA 
mutator allele. The reason is that the primordial germ 
cells of a heterozygous mother contain one copy of the 
mutant POLG allele and this could cause accumulation of 
a small amount of mtDNA mutations during their 
proliferation and maturation into oocytes. A genetic 
bottleneck occurs after the oocyte is fertilized whereby a 
small subset of all mtDNA molecules are partitioned into 
the primordial germ cells of the next generation [17]. 
Subsequent rounds of replication in the wt embryo are 
then carried out by only wt POLG, whereas in the 
mtDNA mutator embryo proofreading-deficient POLG is 
used. As a result, the embryo with the mutator allele will 
continue to introduce new mutations, whereas the wt 
embryo will amplify only the pre-existing mutations with 
high fidelity. This may explain why wt littermates of 
mtDNA mutator mice may have a moderately increased 
mutation load in comparison with other wild-type mice 
whose mitochondria have never come in contact with the 
mtDNA mutator allele. Heterozygous animals from the 
same cross might continue to accumulate random 
mtDNA mutations, but to a much lesser extent than 
mtDNA mutator mice. The pedigree of the analyzed 
wild-type mice is therefore an important factor to 
consider when determining mtDNA mutation loads. 
 
In order to resolve this issue, we believe that a direct 
cloning and sequencing approach should be used. This 
would involve the cloning of large fragments or an 
entire mtDNA molecule into a vector, without the use of 
an intermediate PCR step [18]. In this way PCR-
induced errors will be avoided and a more complete 
picture of the distribution of mutations on the 
population of mtDNA molecules will be achieved. 
Direct cloning and sequencing has 3 major drawbacks. 
First, it is labour intensive. Second, it would require a 
large sequencing effort to sample the same magnitude 
of bases as a RMC assay, making sequencing costs 
prohibitive. Finally, cloning of small amounts of sample 
DNA is often inefficient and studying single cells is 
therefore not possible at the moment. Alternatively, the 
cloning step could be circumvented by usage of newly 
developed deep sequencing techniques that could be 
quantitative simply because the same region of the 
mtDNA would be sequenced over and over again. 
However, many deep sequencing methods have inherent 
error rates, which may obscure somatic mtDNA 
mutation loads.  
 
In a recently published paper, Loeb and co-workers  sug- 
gest that a third type of mtDNA mutation, besides the 
very abundant point mutations and linear deletions we 
have reported [12] are the main driving force behind the 
shortened lifespan in mtDNA mutator mice [19]. This 
third type of mutation is circular mtDNA molecule with 
large deletions of several thousand base pairs. The main 
argument for this conclusion is that the RMC method 
detects a 500-fold increase of mtDNA point mutations 
in heterozygous, Polg
+/mut in comparison with wild-type 
mice, despite the fact the heterozygous mice have a 
normal lifespan [15]. The authors also reported that 
circular mtDNA molecules with deletions are highly 
increased in frequency throughout the lifetime of the 
mtDNA mutator mouse. Similar molecules are also 
found to accumulate in the wt and Polg
+/mut mice , but to 
a much lesser extent (10- 100 times lower). In light of 
this evidence they conclude that the circular mtDNA 
molecules with deletions correlate much better with the 
phenotype and therefore must be the driving force 
behind the premature aging of mtDNA mutator mice 
[19]. However, their study is purely correlative and it 
does not take into account threshold levels that are the 
imperative in mitochondrial genetics. In their study, 
they have estimated only the relative amount of circular 
mtDNA molecules with deletions between genotypes. 
To estimate the importance of these circular mtDNA 
molecules with deletions it is necessary to know what 
fraction of the total mtDNA they represent. 
 
We recently attempted to detect these deletions using 
long extension PCR technique.  As controls, we used 
two strains of mice with known amounts of deletions, 
the mito-mouse and the deletor mouse [20, 21]. These 
mouse strains carry circular mtDNA molecules with 
single (mito-mice) or multiple (deletor-mice) deletions 
in their mitochondria. Although we have robustly 
detected deleted mtDNA molecules in serial dilutions of 
these control samples we were not able to detect any 
deletions in mtDNA mutator heart or liver samples. 
Recently, Kraytsberg et. al used single molecule long 
extension PCR to detect deletions in mtDNA mutator 
samples provided by Loeb and co-workers [22]. They 
did not detect deleted mtDNA among more than 320 
amplified molecules from duodenum and 144 molecules 
from heart of mtDNA mutator mice [22]. This 
completely agrees with our data obtained from heart and 
liver of mtDNA mutator mice. Kraytsberg et. al 
detected some mtDNA deletions in brain tissue, but 
estimate the relative levels to be around 1% and they 
argue that this could be an overestimation [22].    
 
It is unclear how these rare circular molecules with 
deletions could be the major driving force behind the 
shortened lifespan in the mutator mice. The mitomice 
with deletions in up to 30% of all mtDNA molecules do 
not die early, whereas those with deletions in 70% 
suffer from renal failure [23]. The deletor mouse, 
although generating multiple deletions of the same 
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premature aging phenotype.  The deletor mice have 
normal lifespan but develop mitochondrial myopathy 
late in life [21]. Furthermore, deletions are not related to 
Parkinson’s disease until they reach a threshold of 
around 52% in dopaminergic neurons of humans [24]. 
The same is true for most diseases caused by mutations 
in mtDNA. There is always a threshold level of 
mutation that has to be reached before the mutation 
causes respiratory chain dysfunction. This threshold 
level will vary depending on mutation, but is generally 
between 60% (for deletions) - 90% (point mutations) 
[25]. In the mtDNA mutator mouse the mutations are 
spread out over the genome and a very high threshold 
level of a particular mutation might not be reached. 
However, if every molecule accumulates approximately 
20 mutations, many of these will be in protein coding 
genes. For COXI for example there is an 88% chance 
that the gene contains at least 1 mutation in a specific 
mtDNA molecule and a 61% chance that it contains at 
least 2 mutations of which 40% will cause amino acid 
change. Then there are another 12 genes for which 
numbers are slightly different depending on the size of 
the genes. Assuming random distribution of the 
mutations, a threshold level will be reached easily, not 
by one specific mutation, but by the sum of all different 
mutations. Deletions, though affecting many base pairs, 
still need to be at significant levels to cause 
mitochondrial dysfunction. It has been estimated that 
there is about 1000 point mutations for every single 
deleted mtDNA molecule in mtDNA mutator mice (if 
there is >0.02 deletion per mtDNA molecule) [22]. This 
also means that mtDNA mutator mice have about 800 
additional point mutations for every additional deletion 
when compared to Polga
+/mut animals [22]. 
 
Loeb and co-workers do not report increased amounts of 
deletions in COX-negative cells (cytochrome c oxidase 
deficient cells – indicating mitochondrial dysfunction), 
only an increase in point mutations [19]. Large circular 
mtDNA deletions typically span over several protein 
coding genes and include a number of tRNA genes. 
Therefore, consequences of the large deletions could be 
detected as a reduction in mitochondrial transcript levels 
or as a decrease in translation of mitochondrially-
encoded proteins. This, however, does not seem to be the 
case. We found that the pattern of transcriptional change 
was more consistent with increased activity from the 
heavy strand promoter, rather than a loss of components 
via deletions. Translation was also normal, but we did 
observe increased protein turnover [26]. So the 
mechanism by which these rare, circular mtDNA 
molecules with deletions would be causing the premature 
aging phenotype remains unclear. 
 
So what have we learned from the mtDNA mutator 
mouse? Are mtDNA mutations relevant in normal 
aging? Clearly wt mice never accumulate the same level 
of point mutations as mtDNA mutator mouse. They do, 
however, acquire mitochondrial dysfunction with old 
age, as do the mtDNA mutator mice. This indicates 
mitochondrial dysfunction as not only being correlated 
to aging, but also causative. Results from mtDNA 
mutator mice clearly show that mutations in mtDNA 
can cause problems that resemble premature aging. Of 
these mutations, the amino acid changing mutations in 
protein coding genes seem to be the most deleterious 
[26]. This is in agreement with a recent finding than 
non-synonymous mutations that change amino acids in 
respiratory chain subunits are strongly selected against 
and very rarely emerge in future generations, whereas 
tRNA and rRNA mutations seemed to have less severe 
functional consequences and could easily be inherited 
[27]. In addition to loss of function mutations there 
could be dominant deleterious mutations, like the C>T 
mutation at nucleotide 5545 of mtDNA that cause 
pathology at very low levels [28]. One attractive 
candidate for the failure of the organism to thrive comes 
from the finding that stem cell function in the mtDNA 
mutator mice seems to be altered (Ahlquist et al. 
unpublished results). On the organismal level, it 
remains to be determined what type of changes and in 
which cells have the most important effects. Additional 
studies on mtDNA mutator mice in conjunction with old 
control mice might be able to dissect out which changes 
are important and which are just correlative in the way 
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